Division of Urologic Surgery

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Nephrectomy 69%
3. Prostate 50%
4. Kidney 42%
5. Prostatectomy 39%
6. Robotics 37%
7. Prostate-Specific Antigen 36%
8. Dutasteride 34%
9. Urinary Bladder 29%
10. Neoplasms 28%
11. Biopsy 27%
12. Pelvic Pain 22%
13. Early Detection of Cancer 22%
14. Lower Urinary Tract Symptoms 21%
15. Urinary Bladder Neoplasms 20%
16. Renal Cell Carcinoma 20%
17. Prostatic Hyperplasia 18%
18. Chronic Pain 17%
19. Cystectomy 16%
20. Interstitial Cystitis 16%
21. Therapeutics 14%
22. Ovarian Neoplasms 12%
23. Overactive Urinary Bladder 12%
24. Swine 11%
25. Lung Neoplasms 11%
26. Laparoscopy 10%
27. Finasteride 10%
28. Pain 10%
29. Surgeons 10%
30. Colorectal Neoplasms 10%
31. Urinary Incontinence 9%
32. Ureter 9%
33. Urinary Tract 9%
34. Cryosurgery 9%
35. Operative Time 9%
36. Percutaneous Nephrolithotomy 8%
37. Survival 8%
38. Placebos 8%
39. Mortality 8%
40. Recurrence 8%
41. Serum 8%
42. Genome-Wide Association Study 7%
43. Warm Ischemia 7%
44. Kidney Neoplasms 7%
45. Watchful Waiting 7%
46. Urinary Tract Infections 7%
47. Urine 7%
48. Single Nucleotide Polymorphism 7%
49. Lymph Node Excision 7%
50. Carcinoma 7%
51. Databases 7%
52. Artificial Urinary Sphincter 7%
53. Urinary Diversion 6%
54. Protein-Tyrosine Kinases 6%
55. Odds Ratio 6%
56. Urologists 6%
57. Wounds and Injuries 6%
58. Confidence Intervals 6%
59. Length of Stay 6%
60. Nephroureterectomy 6%
61. Neoplasm Grading 6%
62. Incidence 6%
63. Nephrons 6%
64. Quality of Life 5%
65. Stress Urinary Incontinence 5%
66. Guidelines 5%
67. Castration 5%
68. Urology 5%
69. Morbidity 5%
70. Comorbidity 5%
71. Safety 5%
72. Equipment and Supplies 5%
73. Multiparametric Magnetic Resonance Imaging 5%
74. Magnetic Resonance Imaging 5%
75. Pediatrics 5%
76. Digital Rectal Examination 5%
77. Systematic Reviews 5%
78. Androgens 5%
79. Surgical Instruments 5%
80. Pressure 5%
81. Population 5%
82. Learning Curve 5%
83. Stents 5%
84. Ureteroscopy 5%
85. Body Mass Index 5%
86. Margins of Excision 5%